D. Comb_Synop-Solicit_ Amendment 1.docx

DOCX document 30 KB Posted

Attached to
Compound, N-(3-(2-oxopyrrolidin-1-yl)propyl)-4-(6-phenylimidazo[1, 5-a]pyrazin-3-yl)benzamide, greater than 95% purity by LCMS and NMR
Solicitation number
75N95023Q00134
Issued by

View the file

Other files

File Type Posted
D. Attachment 5 - NIH Invoice and Payment Instructions without IPP (Oct 2022).pdf PDF
D. Attachment 1 - Purchase Description - 200g synthesis_FINAL.pdf PDF
D. Attachment 4 - FAR 52.225-2 Buy American Certificate (Oct 2022).pdf PDF
D. Attachment 6 - NIH Invoice and Payment Instructions with IPP (April 2022).pdf PDF
D. Attachment 3 - FAR 52.212-5 (Dec 2022).pdf PDF
D. Attachment 2 - FAR 52.212-4 Addendum.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

AMENDMENT #1:

RFQ 75N95023Q00134

The purpose of this Amendment is to answer the following questions:

1) Is the 200g material GMP or non-GMP?

Non-GMP

2) What is the CAS#?

As of today, there is no CAS#

ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED.

File details come from the government source that posted it. Updated .